March 5, 2021
Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe
March 1, 2021
Rare Disease Week 2021 – Interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi
March 1, 2021
EuropaBio Celebrates 25 Years of Biotech Innovation with 2021 Anniversary Programme
February 24, 2021
European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback
February 15, 2021
The Business of Biotechnology: Growing for Europe’s tomorrow
February 12, 2021
EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion
February 12, 2021
EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare
February 4, 2021
EuropaBio draft response to the IIA on European Health Data Space
February 2, 2021
Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)
January 29, 2021
Building a European Health Union
January 28, 2021
European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation
January 20, 2021
Revision of the EU legislation on medicines for children and rare diseases
December 24, 2020
Joint Statement: Comitology Reform Threatens Innovation
December 20, 2020
EuropaBio Comments on the Draft Delegated Act on Climate-Related Objectives under the Taxonomy Regulation
November 30, 2020
Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
November 25, 2020
An EU IP Action Plan for strong industrial ecosystems
November 25, 2020
EuropaBio Statement on the EU Pharmaceutical Strategy
November 10, 2020
Create sustainable bio-based and biodegradable plastics
November 2, 2020
EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association
October 20, 2020
EuropaBio on Use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making
October 19, 2020
Application of the ATMP Hospital Exemption in the EU
October 7, 2020
Nobel Prize for Genome Editing Pioneers
October 2, 2020
#EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference
September 30, 2020
EuropaBio Patient engagement with the European Medicines Agency
September 24, 2020
Genome editing FAQ
September 3, 2020
Novartis’s Andrew Topen appointed as new Chairman of EuropaBio
August 24, 2020
Genome-Edited Products and Projects: Resources and Examples
August 13, 2020
Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations
August 3, 2020
Joint Statement on the Health Innovation Partnership Proposal
July 30, 2020
Joint response of EuropaBio and BIO on the EU Data Strategy Consultation
July 30, 2020
EuropaBio response to the public consultation on the Roadmap for an EU Pharmaceutical Strategy
 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe

FOLLOW US HERE


Keep up with what is happening in the Biotech sector by connecting with us on social media!


facebook
twitter
instagram
linkedin
youtube
 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
Become a member